Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T12:07:12.820Z Has data issue: false hasContentIssue false

Breeding medicinal plant, periwinkle [Catharanthus roseus (L) G. Don]: a review

Published online by Cambridge University Press:  02 May 2016

R. N. Kulkarni*
Affiliation:
CSIR – Central Institute of Medicinal Plants (CIMAP) Research Centre, Bangalore 560 065, Karnataka, India
K. Baskaran
Affiliation:
CSIR – Central Institute of Medicinal Plants (CIMAP) Research Centre, Bangalore 560 065, Karnataka, India
Tripta Jhang
Affiliation:
Genetics & Plant Breeding Division, CSIR–CIMAP, Lucknow 226 015, UP, India
*
*Corresponding author. E-mail: krnpbg@yahoo.co.in
Rights & Permissions [Opens in a new window]

Abstract

Periwinkle [Catharanthus roseus (L) G. Don] has become one of the very extensively investigated medicinal plants after the discovery of two powerful anti-cancer alkaloids, vinblastine and vincristine, in its leaves more than 50 years ago. These alkaloidal drugs are still in clinical use. Also, periwinkle is still the only source of these alkaloids and their precursors, catharanthine and vindoline. Low concentrations of these alkaloids in the plant and, therefore, high costs of their extraction have led to tremendous efforts towards understanding their biosynthesis and exploration of alternate ways of their production such as, chemical synthesis, cell, tissue and hairy root cultures, and metabolic engineering of heterologous organisms. Literature on this plant is quite voluminous, with an average of about 80 publications per year during last three decades (1985–2015). Nearly 60% of these publications are on physiology, biochemistry, cell and tissue culture, phytochemistry, metabolic and genetic engineering aspects. In spite of these efforts, an economically viable alternative to field-grown periwinkle plants as a source of these alkaloids has not yet been found. Biosynthesis of C. roseus alkaloids is a complex process involving many genes, enzymes, regulators, inter- and intra-cellular transporters, cell types, organelles and tissues and its current understanding is still considered to be incomplete to produce C. roseus alkaloids through metabolic engineering/synthetic biology. Till such time, breeding periwinkle varieties with higher concentrations of anti-cancer alkaloids for cultivation can be an alternate approach to meet the demand for these alkaloids and reduce their costs. While literature on cell and tissue culture, phytochemistry, metabolic and genetic engineering aspects of periwinkle has been reviewed periodically, crop production and plant breeding aspects have received little attention. In this paper, an attempt has been made to bring together published information on genetics and breeding of periwinkle as a medicinal plant. Some probable constraints which may have hindered taking up periwinkle breeding are identified. Initially, quite a few attempts have been made at genetic improvement of periwinkle through induced polyploidy, and subsequently through induced mutagenesis. Mutations, both natural and induced, provide a valuable resource for use in breeding and in functional and reverse genomics research. It is only during last 6–7 years, genetic diversity has been assessed using molecular markers and very recently molecular markers have been identified for marker-assisted selection for alkaloid yield.

Information

Type
Research Article
Copyright
Copyright © NIAB 2016 
Figure 0

Fig. 1. Distribution (%) of publications on periwinkle in different subject areas during the period 1963–2015 (search with key words C. roseus or V. roseus at websites http://newcrops.com.au/; http://www.ncbi.nlm.nih.gov/pubmed and https://scifinder.cas.org/scifinder).

Figure 1

Fig. 2. Number of publications on periwinkle in different subject areas during the period 1963–2015.

Supplementary material: File

Kulkarni supplementary material

Fig. 1S

Download Kulkarni supplementary material(File)
File 120.5 KB
Supplementary material: Image

Kulkarni supplementary material

Fig. 2S

Download Kulkarni supplementary material(Image)
Image 97.7 KB
Supplementary material: Image

Kulkarni supplementary material

Fig. 3S

Download Kulkarni supplementary material(Image)
Image 258.3 KB
Supplementary material: File

Kulkarni supplementary material

Fig. 4S

Download Kulkarni supplementary material(File)
File 12.6 KB
Supplementary material: Image

Kulkarni supplementary material

Fig. 5S

Download Kulkarni supplementary material(Image)
Image 152.7 KB
Supplementary material: Image

Kulkarni supplementary material

Fig. 6S

Download Kulkarni supplementary material(Image)
Image 321.8 KB
Supplementary material: Image

Kulkarni supplementary material

Fig. 7S

Download Kulkarni supplementary material(Image)
Image 227.3 KB
Supplementary material: File

Kulkarni supplementary material

Figure Caption

Download Kulkarni supplementary material(File)
File 18.1 KB